Endocrinology Section, Department of Medicine, Hospital General de Granollers, Granollers, Spain; School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.
DAP‑Cat group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain; Institut de Recerca Hospital de la Santa Creu i Sant Pau (IIBSantPau), Barcelona, Spain.
Diabetes Res Clin Pract. 2022 Sep;191:110031. doi: 10.1016/j.diabres.2022.110031. Epub 2022 Aug 5.
To assess the prevalence of autoimmune diseases (AID) in patients with type 1 diabetes (T1D) and to evaluate whether the rate of diabetes-related complications differs depending on the presence of AID.
Cross-sectional analysis of 13,570 T1D patients aged ≥ 18 years registered in the SIDIAP database. The association between AID and diabetes-related complications was assessed by multivariable logistic regression models.
The prevalence of AID was 18.3% with thyroid AID being the most common. Patients with T1D and AID were more often female and their current age, age of diabetes onset and diabetes duration were higher. Patients with only thyroid AID experienced a lower risk of peripheral artery disease (odds ratio [OR] = 0.51, 95%; confidence interval [CI] 0.31 to 0.81) and kidney disease (OR = 0.68, 95%; 95% CI 0.54 to 0.85), whereas patients with other AID had an increased risk of ischemic heart disease (OR = 1.48, 95%; 95% CI 1.04 to 2.06).
The burden of diabetes-related complications in patients with T1D differs according to the type of additional AID. The presence of diabetes complications is lower in those with autoimmune thyroid disease while the presence of other AID is associated with higher rates of ischemic heart disease.
评估 1 型糖尿病(T1D)患者中自身免疫性疾病(AID)的患病率,并评估糖尿病相关并发症的发生率是否取决于 AID 的存在。
对 SIDIAP 数据库中登记的 13570 名年龄≥18 岁的 T1D 患者进行横断面分析。采用多变量逻辑回归模型评估 AID 与糖尿病相关并发症之间的关系。
AID 的患病率为 18.3%,其中甲状腺 AID 最为常见。患有 T1D 和 AID 的患者中女性更多,其当前年龄、糖尿病发病年龄和糖尿病病程更长。仅患有甲状腺 AID 的患者发生外周动脉疾病(比值比 [OR] = 0.51,95%;置信区间 [CI] 0.31 至 0.81)和肾脏疾病(OR = 0.68,95%;95% CI 0.54 至 0.85)的风险较低,而患有其他 AID 的患者发生缺血性心脏病(OR = 1.48,95%;95% CI 1.04 至 2.06)的风险增加。
T1D 患者的糖尿病相关并发症负担因附加 AID 的类型而异。患有自身免疫性甲状腺疾病的患者发生糖尿病并发症的风险较低,而患有其他 AID 的患者发生缺血性心脏病的风险较高。